| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Christopher Dandoy | Q57010134 |
| P2093 | author name string | Adam Nelson | |
| Gregory Wallace | |||
| Javier El-Bietar | |||
| Kasiani C Myers | |||
| Sonata Jodele | |||
| Benjamin L Laskin | |||
| P2860 | cites work | The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents | Q22305963 |
| Molecular pathogenesis of pulmonary arterial hypertension | Q24634317 | ||
| The contribution of endothelial activation and injury to end-organ toxicity following allogeneic hematopoietic stem cell transplantation | Q37045911 | ||
| Urinary cytokines after HCT: evidence for renal inflammation in the pathogenesis of proteinuria and kidney disease | Q37626972 | ||
| Strict blood-pressure control and progression of renal failure in children | Q43257210 | ||
| Performance of cystatin C-based equations in a pediatric cohort at high risk of kidney injury. | Q44190124 | ||
| Distinct deleterious effects of cyclosporine and tacrolimus and combined tacrolimus-sirolimus on endothelial cells: protective effect of defibrotide. | Q44840961 | ||
| Pericardial effusion in pediatric SCT recipients with thrombotic microangiopathy. | Q53061953 | ||
| Nephrotic syndrome associated with thrombotic microangiopathy following allogeneic stem-cell transplantation for myelodysplastic syndrome | Q79885978 | ||
| Risk factors and severe outcome in thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation | Q80252186 | ||
| Thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation: an autopsy study | Q80487619 | ||
| Thrombotic nephropathy and pulmonary hypertension following autologous bone marrow transplantation in a patient with acute lymphoblastic leukemia: case report | Q82674368 | ||
| Endothelial vulnerability and endothelial damage are associated with risk of graft-versus-host disease and response to steroid treatment | Q87414996 | ||
| A new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury | Q26992169 | ||
| Pulmonary hypertension after hematopoietic stem cell transplantation | Q27024332 | ||
| Intestinal thrombotic microangiopathy after allogeneic bone marrow transplantation: a clinical imitator of acute enteric graft-versus-host disease. | Q33360369 | ||
| Intestinal thrombotic microangiopathy following reduced-intensity umbilical cord blood transplantation | Q33367345 | ||
| Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation | Q33367451 | ||
| Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group | Q33373889 | ||
| Intestinal perforation secondary to haematopoietic stem cell transplant associated thrombotic microangiopathy | Q33384648 | ||
| Chronic kidney disease, thrombotic microangiopathy, and hypertension following T cell-depleted hematopoietic stem cell transplantation | Q33388255 | ||
| Early clinical indicators of transplant-associated thrombotic microangiopathy in pediatric neuroblastoma patients undergoing auto-SCT. | Q33391308 | ||
| Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation | Q33391457 | ||
| Advances in our understanding of the pathogenesis of glomerular thrombotic microangiopathy | Q33392316 | ||
| Diagnosis of intestinal graft-versus-host disease and thrombotic microangiopathy after allogeneic stem cell transplantation | Q33400901 | ||
| Pulmonary arterial hypertension in pediatric patients with hematopoietic stem cell transplant-associated thrombotic microangiopathy. | Q33403203 | ||
| Thrombotic microangiopathy associated with sirolimus level after allogeneic hematopoietic cell transplantation with tacrolimus/sirolimus-based graft-versus-host disease prophylaxis | Q33403897 | ||
| Comprehensive genetic analysis of complement and coagulation genes in atypical hemolytic uremic syndrome | Q33410276 | ||
| Eculizumab therapy in children with severe hematopoietic stem cell transplantation-associated thrombotic microangiopathy. | Q33412325 | ||
| Biomarkers of terminal complement activation confirm the diagnosis of aHUS and differentiate aHUS from TTP. | Q33414383 | ||
| Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults | Q33415603 | ||
| Hematopoietic stem cell transplant-associated thrombotic microangiopathy: review of pharmacologic treatment options | Q33417613 | ||
| Abnormal echocardiography 7 days after stem cell transplantation may be an early indicator of thrombotic microangiopathy | Q33418088 | ||
| Pretransplant-corrected QT dispersion as a predictor of pericardial effusion after pediatric hematopoietic stem cell transplantation | Q33420131 | ||
| Use of Eculizumab in Patients With Allogeneic Stem Cell Transplant-Associated Thrombotic Microangiopathy: A Study From the SFGM-TC. | Q33420170 | ||
| Histologic Features of Intestinal Thrombotic Microangiopathy in Pediatric and Young Adult Patients after Hematopoietic Stem Cell Transplantation | Q33424204 | ||
| Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy | Q33424902 | ||
| Eculizumab in Transplant-Associated Thrombotic Microangiopathy. | Q33425079 | ||
| Variable Eculizumab Clearance Requires Pharmacodynamic Monitoring to Optimize Therapy for Thrombotic Microangiopathy after Hematopoietic Stem Cell Transplantation. | Q33426602 | ||
| The genetic fingerprint of susceptibility for transplant-associated thrombotic microangiopathy | Q33427838 | ||
| Albuminuria in hematopoietic cell transplantation patients: prevalence, clinical associations, and impact on survival | Q33570908 | ||
| Hypertension in long-term survivors of pediatric hematopoietic cell transplantation | Q33729496 | ||
| Captopril and losartan for mitigation of renal injury caused by single-dose total-body irradiation | Q34822417 | ||
| Diagnosis and management of pulmonary arterial hypertension | Q35222937 | ||
| Loss of endothelial thrombomodulin predicts response to steroid therapy and survival in acute intestinal graft-versus-host disease | Q36366581 | ||
| Chronic kidney disease after liver, cardiac, lung, heart-lung, and hematopoietic stem cell transplant | Q36585425 | ||
| Spectrum of renal pathology in hematopoietic cell transplantation: a series of 20 patients and review of the literature | Q36912000 | ||
| P433 | issue | 2 | |
| P921 | main subject | pathophysiology | Q1135939 |
| P304 | page(s) | 181-190 | |
| P577 | publication date | 2016-04-25 | |
| P1433 | published in | Transfusion and Apheresis Science | Q15758507 |
| P1476 | title | New approaches in the diagnosis, pathophysiology, and treatment of pediatric hematopoietic stem cell transplantation-associated thrombotic microangiopathy | |
| P478 | volume | 54 |
| Q90184241 | Adverse Effects of Virus-Specific T-Cell Therapy: An Integrative Review |
| Q64092519 | Asymmetric dimethylarginine - a prognostic marker for transplant outcome? |
| Q55431201 | Bone marrow transplant-associated thrombotic microangiopathy without peripheral blood schistocytes: a case report and review of the literature. |
| Q50892145 | Circulating dsDNA, endothelial injury, and complement activation in thrombotic microangiopathy and GVHD. |
| Q58553367 | Clinical and morphological practices in the diagnosis of transplant-associated microangiopathy: a study on behalf of Transplant Complications Working Party of the EBMT |
| Q28067041 | Clinical evaluation of thrombotic microangiopathy: identification of patients with suspected atypical hemolytic uremic syndrome |
| Q42086661 | Complement C5-inhibiting therapy for the thrombotic microangiopathies: accumulating evidence, but not a panacea |
| Q57456627 | Complement-mediated thrombotic microangiopathy as a link between endothelial damage and steroid-refractory GVHD |
| Q52774563 | Double trouble: Complement-mediated thrombotic microangiopathy in patients with hemoglobinopathies after stem cell transplantation. |
| Q28069228 | Hematopoietic cell transplantation-associated thrombotic microangiopathy: a review of pathophysiology, diagnosis, and treatment |
| Q48588474 | High Levels of Morbidity and Mortality Among Pediatric Hematopoietic Cell Transplant Recipients With Severe Sepsis: Insights From the Sepsis PRevalence, OUtcomes, and Therapies International Point Prevalence Study. |
| Q52718166 | High-dose Carboplatin/Etoposide/Melphalan increases risk of thrombotic microangiopathy and organ injury after autologous stem cell transplantation in patients with neuroblastoma. |
| Q47912606 | Impact of treatment and outcomes for patients with posttransplant drug-associated thrombotic microangiopathy |
| Q89777302 | In vitro evidence of complement activation in transplantation-associated thrombotic microangiopathy |
| Q90623554 | Interferon-complement loop in transplant-associated thrombotic microangiopathy |
| Q38806679 | Is complement blockade an acceptable therapeutic strategy for hematopoietic cell transplant-associated thrombotic microangiopathy? |
| Q59358378 | Neurological complications of hematopoietic cell transplantation in children and adults |
| Q90435254 | Safety and effectiveness of eculizumab for pediatric patients with atypical hemolytic-uremic syndrome in Japan: interim analysis of post-marketing surveillance |
| Q92092550 | Severe, persistent neurotoxicity after transplant-associated thrombotic microangiopathy in a pediatric patient despite treatment with eculizumab |
| Q91229941 | Successful Treatment of Veno-occlusive Disease, Transplantation-Associated Thrombotic Microangiopathy, and Acute Graft-vs-Host Disease in a Patient with Relapsed Epstein-Barr Hemophagocytic Lymphohistiocytosis After Haploidentical Hematopoietic Stem |
| Q52777491 | The injured heart: early cardiac effects of hematopoietic stem cell transplantation in children and young adults. |
| Q50085453 | Thrombotic Microangiopathy and the Kidney |
| Q52758442 | Thrombotic microangiopathy associated with monoclonal gammopathy following autologous hematopoietic stem cell transplantation for neuroblastoma in a young child. |
| Q92087747 | Transplant-associated thrombotic microangiopathy: Diagnostic challenges and management strategies |
| Q90068152 | [Pulmonary arterial hypertension caused by graft-related thrombotic microangiopathy after ETP-ALL haplotype hematopoietic stem cell transplantation: a case report and literatures review] |
Search more.